Physiology of Gonadotrope Axis (ERL U1133 INSERM)

 

Selected publications

1/ Avet C, Paul EN, Garrel G, Grange-Messent V, L’Hôte D, Denoyelle C, Corre R, Dupret JM, Lanone S, Boczkowski J, Simon V, Cohen-Tannoudji J. Carbon Black Nanoparticles Selectively Alter Follicle-Stimulating Hormone Expression <i>in vitro</i> and <i>in vivo</i> in Female Mice. Front Neurosci. 2021 Dec 6;15:780698.

2/ Cluzet V, Devillers MM, Petit F, Pierre A, Giton F, Airaud E, L’Hôte D, Leary A, Genestie C, Treilleux I, Mayeur A, Katzenellenbogen JA, Kim SH, Cohen- Tannoudji J, Chauvin S, Guigon CJ. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism. J Pathol. 2021 Dec 3.

3/ Pierre A, Mayeur A, Marie C, Cluzet V, Chauvin J, Frydman N, Grynberg M, Cohen-Tannoudji J, Guigon CJ, Chauvin S. Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis. Int J Mol Sci. 2021 May 10;22(9):5046

4/ Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol. 2019 Feb 1;240(2):215-228.

5/ Pacini V, Petit F, Querat B, Laverriere JN, Cohen-Tannoudji J, L’hôte D. Identification of a pituitary ERα-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor. Epigenetics Chromatin. 2019 Aug 7;12(1):48.

 

 

 

Publications in peer-reviewed journals (since 2017)

** Publications communes avec d’autres équipes de BFA.

Quartile (Scimago Journal & Country Rank) indiqué à la fin de chaque référence.

 

Original articles

 

2023

Marie C, Pierre A, Mayeur A, Giton F, Corre R, Grynberg M, Cohen-Tannoudji J, Guigon CJ, Chauvin S. Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome. Int J Mol Sci. 2023 Nov 24;24(23):16689. (Q1)

Le Ciclé C, Pacini V, Rama N, Tauszig-Delamasure S, Airaud E, Petit F, de Beco S, Cohen-Tannoudji J, L’hôte D. The Neurod1/4-Ntrk3-Src pathway regulates gonadotrope cell adhesion and motility. Cell Death Discov. 2023 Sep 1;9(1):327. (Q1)

Devillers MM, François CM, Chester M, Corre R, Cluzet V, Giton F, Cohen-Tannoudji J, Guigon CJ. Androgen receptor signaling regulates follicular growth and steroidogenesis in interaction with gonadotropins in the ovary during mini-puberty in mice. Front Endocrinol (Lausanne). 2023 Apr 19;14:1130681. (Q1)

2022

** Garrel G, Rouch C, L’Hôte D, Tazi S, Kassis N, Giton F, Dairou J, Dournaud P, Gressens P, Magnan C, Cruciani-Guglielmacci C, Cohen-Tannoudji J. Disruption of Pituitary Gonadotrope Activity in Male Rats After Short- or Long-Term High-Fat Diets Is Not Associated With Pituitary Inflammation. Front Endocrinol (Lausanne). 2022 Apr 13; 13: 877999. (Q1)

Cluzet V, Devillers M, Petit F, Pierre A, Giton F, Airaud E, L’Hôte D, Leary A, Genestie C, Treilleux I, Mayeur A, Katzenellenbogen JA, Kim SH, Cohen- Tannoudji J, Chauvin S, Guigon CJ. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism. J Pathol.  2022 Mar; 256(3): 335-348. (Q1). https://presse.inserm.fr/journee-mondiale-contre-le-cancer-linserm-plus-que-jamais-mobilise/44565/

Jolivet G, Daniel-Carlier N, Harscoët E, Airaud E, Dewaele A, Pierson C, Giton F, Boulanger L, Daniel N, Mandon-Pépin B, Pannetier M, Pailhoux E. Fetal Estrogens are not Involved in Sex Determination But Critical for Early Ovarian Differentiation in Rabbits. Endocrinology. 2022 Jan 1; 163. (Q1)

2021

Racine C, Genêt C, Bourgneuf C, Dupont C, Plisson-Petit F, Sarry J, Hennequet-Antier C, Vigouroux C, Mathieu d’Argent E, Pierre A, Monniaux D, FabreS, di Clemente N. New Anti-Müllerian Hormone Target Genes Involved in Granulosa Cell Survival in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021 Mar 8; 106(3). (Q1)

** Avet C, Paul EN, Garrel G, Grange-Messent V, L’Hôte D, Denoyelle C, Corre R, Dupret JM, Lanone S, Boczkowski J, Simon V, Cohen-Tannoudji J. Carbon Black Nanoparticles Selectively Alter Follicle-Stimulating Hormone Expression in vitro and in vivo in Female Mice. Front Neurosci. 2021 Dec 6; 15: 780698. (Q2)

Pierre A, Mayeur A, Marie C, Cluzet V, Chauvin J, Frydman N, Grynberg M, Cohen-Tannoudji J, Guigon CJ, Chauvin S. Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis. Int J Mol Sci. 2021 May 10; 22(9): 5046. (Q1)

** Bourgneuf C, Bailbé D, Lamazière A, Dupont C, Moldes M, Farabos D, Roblot N, Gauthier C, Mathieu d’Argent E, Cohen-Tannoudji J, Monniaux D, Fève B, Movassat J, di Clemente N, Racine C. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun. 2021 Feb 16; 12(1): 1064. (Q1)

2020

Cluzet V, Devillers M, Petit F, Chauvin S, François CM, Giton F, Genestie C, di Clemente N, Cohen-Tannoudji J, Guigon CJ. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary. Oncogene. 2020 Feb; 39(9): 1875-1890. (Q1)

Devillers M, Petit F, Giton F, François CM, Juricek L, Coumoul X, Magre S, Cohen-Tannoudji J, Guigon CJ. Age-dependent vulnerability of the ovary to AhR- mediated TCDD action before puberty: Evidence from mouse models. Chemosphere. 2020 Nov; 258:127361. (Q1)

De Cian MC, Gregoire EP, Le Rolle M, Lachambre S, Mondin M, Bell S, Guigon CJ, Chassot AA, Chaboissier MC. R-spondin2 signaling is required for oocyte-driven intercellular communication and follicular growth. Cell Death Differ. 2020 Oct; 27(10): 2856-2871. (Q1)

2019

Pacini V, Petit F, Querat B, Laverriere JN, Cohen-Tannoudji J, L’hôte D. Identification of a pituitary ERα-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor. Epigenetics Chromatin. 2019 Aug 7; 12(1): 48. (Q1)

Manna PR, Ahmed AU, Yang S, Narasimhan M, Cohen-Tannoudji J, Slominski AT, Pruitt K. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective. Cancers (Basel). 2019 May 4; 11(5). (Q1)

Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol. 2019 Feb 1; 240(2): 215-228. (Q1)

Garrel G, Denoyelle C, L’Hôte D, Picard JY, Teixeira J, Kaiser UB, Laverrière JN, Cohen-Tannoudji J. GnRH Transactivates Human AMH Receptor Gene via Egr1 and FOXO1 in Gonadotrope Cells. Neuroendocrinology. 2019; 108(2): 65-83. (Q1)

Ayrout M, Le Billan F, Grange-Messent V, Mhaouty-Kodja S, Lombès M, Chauvin S. Psychoneuroendocrinology, 2019; 99: 47-56. (Q1)

2018

Avet C, Denoyelle C, L’Hôte D, Petit F, Guigon CJ, Cohen-Tannoudji J, Simon V. GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes. PLoS One. 2018 Jul 27; 13(7). (Q1)

Penrad-Mobayed M, Perrin C, L’Hôte D, Contremoulins V, Lepesant JA, Boizet-Bonhoure B, Poulat F, Baudin X, Veitia RA. A role for SOX9 in post-transcriptional processes: insights from the amphibian oocyte. Sci Rep. 2018 May 8; 8(1): 7191. (Q1)

2017

Fouquet B, Pawlikowska P, Caburet S, Guigon C, Mäkinen M, Tanner L, Hietala M, Urbanska K, Bellutti L, Legois B, Bessieres B, Gougeon A, Benachi A, Livera G, Rosselli F, Veitia RA, Misrahi M. A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency. Elife. 2017 Dec 12; 6. (Q1)

Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017 Nov 1; 102(11): 3970-3978. (Q1)

** Simon V, Avet C, Grange-Messent V, Wargnier R, Denoyelle C, Pierre A, Dairou J, Dupret JM, Cohen-Tannoudji J. Carbon Black Nanoparticles Inhibit Aromatase Expression and Estradiol Secretion in Human Granulosa Cells Through the ERK1/2 Pathway. Endocrinology. 2017 Oct 1; 158(10): 3200-3211. (Q1)

Ayrout M, Simon V, Bernard V, Binart N, Cohen-Tannoudji J, Lombès M, Chauvin S. A novel non genomic glucocorticoid signaling mediated by a membrane palmitoylated glucocorticoid receptor cross talks with GnRH in gonadotrope cells. Sci Rep. 2017 May 8; 7(1): 1537. (Q1)

François CM, Petit F, Giton F, Gougeon A, Ravel C, Magre S, Cohen-Tannoudji J, Guigon CJ. A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty. Sci Rep. 2017 Apr 11; 7: 46222. (Q1)

Reviews

Devillers M, Mhaouty-Kodja S, Guigon CJ. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. Int J Mol Sci. 2022 Nov 8; 23(22): 13695.

Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies. Int J Mol Sci. 2022 Jan 3; 23(1): 512.

Querat B. Unconventional Actions of Glycoprotein Hormone Subunits: A Comprehensive Review. Front Endocrinol (Lausanne). 2021 Sep 21; 12: 731966.

di Clemente N, Racine C, Pierre A, Taieb J. Anti-Müllerian Hormone in Female Reproduction. Endocr Rev. 2021 Nov 16; 42(6): 753-782.

Dufour S, Quérat B, Tostivint H, Pasqualini C, Vaudry H, Rousseau K. Origin and Evolution of the Neuroendocrine Control of Reproduction in Vertebrates, With Special Focus on Genome and Gene Duplications. Physiol Rev. 2020 Apr 1; 100(2): 869-943.

Pacini V, Petit F, Quérat B, Laverrière JN, Cohen-Tannoudji J, L’hôte D. ERα orchestre les mécanismes épigénétiques qui déclenchent l’expression du gène Sf-1 au cours de la différenciation du lignage gonadotrope hypophysaire [ERα orchestrates epigenetic mechanisms initiating Sf-1 gene expression during pituitary gonadotrope cell lineage differentiation]. Med Sci (Paris). 2020 Jun-Jul; 36(6-7): 562-565.

Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. [Ovarian estradiol production during mini-puberty: importance of the cross-talk between FSH and AMH]. Med Sci (Paris). 2019 Mar; 35(3): 201-203.

Lannes J, L’Hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. [microRNA and inactivation of the pituitary gonadotrope function]. Med Sci (Paris). 2017 Apr; 33(4): 386-388.

 

---

Publications of the team’s clinicians

2022

Laot L, Sonigo C, Nobre J, Benachi A, Dervin T, El Moujahed L, Mayeur A, Stoppa-Lyonnet D, Steffann J, Grynberg M. Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers? Cancers (Basel). 2022 Nov 24; 14(23): 5769.

Rose M, Jodoin A, Duros S, Sonigo C, Grynberg M, Polak M, da Costa S, Bidet M. Fertility preservation in teenage girls, for non- oncological indications. J Gynecol Obstet Hum Reprod. 2022 Nov; 51(9): 102449.

Rives N, Courbière B, Almont T, Kassab D, Berger C, Grynberg M, Papaxanthos A, Decanter C, Elefant E, Dhedin N, Barraud-Lange V, Béranger MC, Demoor-Goldschmidt C, Frédérique N, Bergère M, Gabrel L, Duperray M, Vermel C, Hoog-Labouret N, Pibarot M, Provansal M, Quéro L, Lejeune H, Methorst C, Saias J, Véronique-Baudin J, Giscard d’Estaing S, Farsi F, Poirot C, Huyghe É. What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. Eur J Cancer. 2022 Sep; 173: 146-166.

Sonigo C, Amsellem N, Mayeur A, Laup L, Pistilli B, Delaloge S, Eustache F, Sifer C, Rakrouki S, Benoit A, Peigné M, Grynberg M. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer. Fertil Steril. 2022 Dec 3: S0015-0282(22)02048-9.

Grzegorczyk-Martin V, Roset J, Di Pizio P, Fréour T, Barrière P, Pouly JL, Grynberg M, Parneix I, Avril C, Pacheco J, Grzegorczyk TM. Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer. J Assist Reprod Genet. 2022 Aug; 39(8): 1937-1949.

Lalami I, Labrosse J, Cedrin-Durnerin I, Comtet M, Vinolas C, Krief F, Sifer C, Peigne M, Grynberg M. Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger? Reprod Biol Endocrinol. 2022 Jun 11; 20(1): 87.

Raad J, Sonigo C, Benoit A, Cedrin-Durnerin I, Sifer C, Sermondade N, Grynberg M. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation. Hum Reprod. 2022 Jun 30; 37(7): 1480-1488.

Bry-Gauillard H, Belin F, Vinolas C, Renoult-Pierre P, Massin N, Young J, Sifer C, Grynberg M. Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. Reprod Biomed Online. 2022 Feb; 44(2): 304-309.

Carles M, Sonigo C, Binois O, Hesters L, Steffann J, Romana S, Frydman N, Mayeur A. Second biopsy for embryos with inconclusive results after preimplantation genetic testing: Impact on pregnancy outcomes. J Gynecol Obstet Hum Reprod. 2022 Oct; 51(8): 102436.

Fiot E, Alauze B, Donadille B, Samara-Boustani D, Houang M, De Filippo G, Bachelot A, Delcour C, Beyler C, Bois E, Bourrat E, Bui Quoc E, Bourcigaux N, Chaussain C, Cohen A, Cohen-Solal M, Da Costa S, Dossier C, Ederhy S, Elmaleh M, Iserin L, Lengliné H, Poujol-Robert A, Roulot D, Viala J, Albarel F, Bismuth E, Bernard V, Bouvattier C, Brac A, Bretones P, Chabbert-Buffet N, Chanson P, Coutant R, de Warren M, Demaret B, Duranteau L, Eustache F, Gautheret L, Gelwane G, Gourbesville C, Grynberg M, Gueniche K, Jorgensen C, Kerlan V, Lebrun C, Lefevre C, Lorenzini F, Manouvrier S, Pienkowski C, Reynaud R, Reznik Y, Siffroi JP, Tabet AC, Tauber M, Vautier V, Tauveron I, Wambre S, Zenaty D, Netchine I, Polak M, Touraine P, Carel JC, Christin-Maitre S, Léger J. Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol). Orphanet J Rare Dis. 2022 Jul 12;17(Suppl 1):261.

 

2021

Herbemont C, Labrosse J, Bennani-Smires B, Cedrin-Durnerin I, Peigne M, Sermondade N, Sarandi S, Vivot A, Vicaut E, Talib Z, Grynberg M, Sifer C. Impact of oxygen tension according to embryo stage of development: a prospective randomized study. Sci Rep. 2021 Nov 16; 11(1): 22313.

Hours A, Toussaint A, De Castelbajac V, Sautter C, Borghese J, Frank S, Coussy F, Laas E, Grandal B, Dumas E, Daoud E, Guerin J, Balezeau T, Feron JG,  Fourchotte V, Kirova Y, Lerebours F, Pierga JY, Guillot E, Santulli P, Grynberg M, Sonigo C, Reyrat E, Soibinet-Oudot P, Reyal F, Hamy AS. Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy. Front Oncol. 2021 Sep 28; 11: 701620.

Carbonnel M, Layoun L, Poulain M, Tourne M, Murtada R, Grynberg M, Feki A, Ayoubi JM. Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women. J Clin Med. 2021 Sep 18; 10(18): 4233.

Sonigo C, Mayeur A, Sadoun M, Pinto M, Benguigui J, Frydman N, Monnot S, Benachi A, Steffann J, Grynberg M. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome? Hum Reprod. 2021 Oct 18; 36(11): 3003-3013.

Christin-Maitre S, Givony M, Albarel F, Bachelot A, Bidet M, Blanc JV,  Bouvattier C, Brac de la Perrière A, Catteau-Jonard S, Chevalier N, Carel JC,  Coutant R, Donadille B, Duranteau L, El-Khattabi L, Hugon-Rodin J, Houang M, Grynberg M, Kerlan V, Leger J, Misrahi M, Pienkowski C, Plu-Bureau G, Polak M,  Reynaud R, Siffroi JP, Sonigo C, Touraine P, Zenaty D. Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome). Ann Endocrinol (Paris). 2021 Dec; 82(6): 555-571.

De Vos M, Grynberg M, Ho TM, Yuan Y, Albertini DF, Gilchrist RB. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet. 2021 Jun; 38(6): 1265-1280.

de Bovis C, Baret C, Grynberg M, Freour T. Intérêt de la théorie des organisations à haute fiabilité en Assistance Médicale à la Procréation (AMP)  [Relevance of the theory of High Reliability Organizations in Assisted Reproductive Technology]. Gynecol Obstet Fertil Senol. 2021 Jun 16: S2468-7189(21)00158-6.

Orvieto R, Venetis CA, Fatemi HM, D’Hooghe T, Fischer R, Koloda Y, Horton M,  Grynberg M, Longobardi S, Esteves SC, Sunkara SK, Li Y, Alviggi C. Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus. Front Endocrinol (Lausanne). 2021 May 10; 12: 675670.

Grynberg M, Labrosse J, Bennani Smires B, Sifer C, Peigne M, Sonigo C. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women? Hum Reprod. 2021 Jun 18; 36(7): 1941-1947.

Gruca A, Ziemska-Legiecka J, Jarnot P, Sarnowska E, Sarnowski TJ, Grynberg M. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development. BMC Bioinformatics. 2021 Apr 8; 22(1): 182.

Mayeur A, Puy V, Windal V, Hesters L, Gallot V, Benoit A, Grynberg M, Sonigo C, Frydman N. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience. J Assist Reprod Genet. 2021 Jul; 38(7): 1767-1775.

Labrosse J, Peigné M, Eustache F, Sifer C, Grynberg M, Cedrin-Durnerin I. Women utilizing oocyte donation have a decreased live birth rate if they displayed a low progesterone level in a previous hormonal replacement mock cycle. J Assist Reprod Genet. 2021 Mar; 38(3): 605-612.

Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study. PLoS Med. 2021 Nov 30; 18(11): e1003857.

Chatzovoulou K, Mayeur A, Gigarel N, Jabot-Hanin F, Hesters L, Munnich A, Frydman N, Bonnefont JP, Steffann J. Mitochondrial DNA mutations do not impact early human embryonic development. Mitochondrion. 2021 May; 58: 59-63.

Herbemont C, Mnallah S, Bennani-Smires B, Peigne M, Cedrin-Durnerin I,  Grynberg M, Sifer C. Cryopreservation of small numbers of human spermatozoa in a Stripper tip: Report of the first live-birth worldwide. Cryobiology. 2021 Apr; 99: 103-105.

M’kacher R, Colicchio B, Marquet V, Borie C, Najar W, Hempel WM,  Heidingsfelder L, Oudrhiri N, Al Jawhari M, Wilhelm-Murer N, Miguet M, Dieterlen A, Deschênes G, Tabet AC, Junker S, Grynberg M, Fenech M, Bennaceur-Griscelli A, Voisin P, Carde P, Jeandidier E, Yardin C. Telomere aberrations, including telomere loss, doublets, and extreme shortening, are increased in patients with infertility. Fertil Steril. 2021 Jan; 115(1): 164-173.

Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D’argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2021 Jan; 256: 492-501.

 

2020

Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, Marca A, Lainas G, Clef NL, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020 Dec 29; 2020(4): hoaa067.

Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E,

Huchon C, Bourdel N, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D’argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers. J Gynecol Obstet Hum Reprod. 2020 Nov 4: 101965.

Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, D’argent Mathieu E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. J Gynecol Obstet Hum Reprod. 2020 Nov 2: 101966.

Sermondade N, Grynberg M, Comtet M, Valdelievre C, Sifer C, Sonigo C. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible. Sci Rep. 2020 Oct 29; 10(1): 18555.

Courbiere B, Lacan A, Grynberg M, Grelat A, Rio V, Arbo E, Solignac C. Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey. PLoS One. 2020 Sep 24; 15(9): e0238945.

Ferrier C, Boujenah J, Poncelet C, Chabbert-Buffet N, Mathieu D’Argent E, Carbillon L, Grynberg M, Darai E, Bendifallah S. Use of the EFI score in endometriosis-associated infertility: A cost-effectiveness study. Eur J Obstet Gynecol Reprod Biol. 2020 Oct; 253: 296-303.

Creux H, Diaz M, Grynberg M, Papaxanthos-Roche A, Chansel-Debordeaux L, Jimenez C, Frantz S, Chevalier N, Takefman J, Hocké C. National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws. J Gynecol Obstet Hum Reprod. 2020 Nov; 49(9): 101902.

Mayeur A, Binois O, Gallot V, Hesters L, Benoit A, Oppenheimer A, Presse M, Zeghari F, BenguigUi J, Grynberg M, Frydman N, Sonigo C. First follow-up of art pregnancies in the context of the COVID-19 outbreak. Eur J Obstet Gynecol Reprod Biol. 2020 Oct; 253: 71-75.

Grynberg M, Jacquesson L, Sifer C. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency. Fertil Steril. 2020 Oct; 114(4): 848-853.

Sonigo C, Le Conte G, Boubaya M, Ohanyan H, Pressé M, El Hachem H, Cedrin-Durnerin I, Benoit A, Sifer C, Sermondade N, Grynberg M. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study. Reprod Sci. 2020 Dec; 27(12): 2247-2256.

Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, Andersen CY, Bühler K, Sunkara SK, Polyzos NP, Strina I, Carbone L, Bento FC, Galliano D, Yarali H, Vuong LN, Grynberg M, Drakopoulos P, Xavier P, Llacer J, Neuspiller F, Horton M, Roque M, Papanikolaou E, Banker M, Dahan MH, Foong S, Tournaye H, Blockeel C, Vaiarelli A, Humaidan P, Ubaldi FM; POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 2020 May 13; 18(1): 45.

Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020 May 1; 2020(2): hoaa009.

Mayeur A, Ahdad N, Hesters L, Grynberg M, Romana S, Sonigo C, Frydman N. Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers? Reprod Biomed Online. 2020 May; 40(5): 684-692.

Affdal AO, Grynberg M, Hessissen L, Ravitsky V. Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists. BMC Med Ethics. 2020 Apr 3; 21(1): 25.

Grynberg M, Mayeur Le Bras A, Hesters L, Gallot V, Frydman N. First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. Ann Oncol. 2020 Apr; 31(4): 541-542.

Sonigo C, Bajeux J, Boubaya M, Eustache F, Sifer C, Lévy V, Grynberg M, Sermondade N. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions. Hematol Oncol. 2020 Oct; 38(4): 560-564.

Benoit A, Grynberg M, Morello R, Sermondade N, Grandazzi G, Moutel G. Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial. BMJ Open. 2020 Feb 10; 10(2): e031739.

Puy V, Mayeur A, Levy A, Hesters L, Raad J, Monnot S, Steffann J, Frydman N. CTG Expansion in the DMPK Gene: Semen Quality Assessment and Outcome of Preimplantation Genetic Diagnosis. J Clin Endocrinol Metab. 2020 Mar 1; 105(3): dgaa041.

 

2019

Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, Bühler K, Sunkara SK, Polyzos NP, Galliano D, Grynberg M, Yarali H, Özbek IY, Roque M, Vuong LN, Banker M, Rienzi L, Vaiarelli A, Cimadomo D, Ubaldi FM. The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists. Front Endocrinol (Lausanne). 2019 Nov 20; 10: 814.

Benoit L, Boujenah J, Poncelet C, Grynberg M, Carbillon L, Nyangoh Timoh K, Touleimat S, Mathieu D’Argent E, Jayot A, Owen C, Lavoue V, Roman H, Darai E, Bendifallah S. Predicting the likelihood of a live birth for women with endometriosis-related infertility. Eur J Obstet Gynecol Reprod Biol. 2019 Nov; 242: 56-62.

Herbemont C, Mnallah S, Grynberg M, Sifer C. [Prospective comparison of different techniques for cryopreservation of small numbers of human spermatozoa]. Gynecol Obstet Fertil Senol. 2019 Nov; 47(11): 797-801.

Ranisavljevic N, Raad J, Anahory T, Grynberg M, Sonigo C. Embryo transfer strategy and therapeutic options in infertile patients with thin endometrium: a systematic review. J Assist Reprod Genet. 2019 Nov; 36(11): 2217-2231.

Sonigo C, Beau I, Binart N, Grynberg M. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage. Int J Mol Sci. 2019 Oct 27; 20(21): 5342.

Grynberg M, Sermondade N. Fertility preservation: should we reconsider the terminology? Hum Reprod. 2019 Oct 2; 34(10): 1855-1857.

Stoeklé HC, Bollet M, Cobat A, Charlier P, Bloch OC, Flatot J, Draghi C, Tolyan V, Hervé C, Desvaux P, Uzan L, Grynberg M, Alcaïs A, Tolédano A, Vogt G. French-style genetics v. 2.0: The « e-CohortE » project. Clin Genet. 2019 Oct; 96(4): 330-340.

Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol. JBRA Assist Reprod. 2019 Aug 22; 23(3): 239-245.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine  E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. Eur J Cancer. 2019 Jul; 116: 35-44.

Sonigo C, Beau I, Binart N, Grynberg M. Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications. Clin Med Insights Reprod Health. 2019 Jun 14; 13: 1179558119854755.

Sonigo C, Sermondade N, Calvo J, Benard J, Sifer C, Grynberg M. Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. Eur J Obstet Gynecol Reprod Biol X. 2019 May 11; 4: 100049.

Grynberg M, Labrosse J. Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria. Front Endocrinol (Lausanne). 2019 Apr 16; 10: 246.

Cédrin-Durnerin I, Isnard T, Mahdjoub S, Sonigo C, Seroka A, Comtet M, Herbemont C, Sifer C, Grynberg M. Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium. Reprod Biomed Online. 2019 Mar; 38(3): 472-480.

Pistilli B, Mazouni C, Zingarello A, Faron M, Saghatchian M, Grynberg M, Spielmann M, Kerbrat P, Roché H, Lorgis V, Bachelot T, Campone M, Levy C, Gonçalves A, Lesur A, Veyret C, Vanlemmens L, Lemonnier J, Delaloge S. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials. Clin Breast Cancer. 2019 Feb; 19(1): 63-70.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertil Steril. 2019 Feb; 111(2): 357-362.

Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod. 2019 Feb 1; 34(2): 374-379.

Herbemont C, El Kouhen I, Brax A, Vinolas C, Dagher-Hayeck B, Comtet M, Calvo J, Sarandi S, Grynberg M, Cédrin-Durnerin I, Sifer C. [Dual trigger with gonadotropin-releasing hormone agonist and hCG to improve oocyte maturation rate]. Gynecol Obstet Fertil Senol. 2019 Jul-Aug; 47(7-8): 568-573.

Papanikolaou EG, Timotheou E, Tatsi P, Janssens H, Grynberg M, Athanasiadis A, Zafeirati C, Najdecki R, Petousis S. COMFFETI, Combined Fresh and Frozen Embryo Transfers per Individual: A New Index of Quality Control for The Performance of emberyologic Labs in The Emerging Era of Segmentation of Cycle and Freeze-All Strategy. Int J Fertil Steril. 2019 Jan; 12(4): 339-342.

Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2019 Jan; 33(1): 1278-1287.

Victoria M, Labrosse J, Krief F, Cédrin-Durnerin I, Comtet M, Grynberg M. Anti Müllerian Hormone: More than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod. 2019 Jan; 48(1): 19-24.

Mayeur A, Ahdad N, Hesters L, Brisset S, Romana S, Tosca L, Tachdjian G, Frydman N. Chromosomal translocations and semen quality: A study on 144 male translocation carriers. Reprod Biomed Online. 2019 Jan; 38(1): 46-55.

Sonigo C, Grynberg M, Bringer S, Sermondade N. Oncofertilité et cancer du sein [Oncofertility and breast cancer]. Bull Cancer. 2019 Dec;106(12S1):S43-S52.

 

2018

Herbemont C, Chekroune S, Bonan S, Cedrin-Durnerin I, Vivot A, Sonigo C, Boujenah J, Grynberg M, Sifer C. Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study. Fertil Steril. 2018 Dec; 110(7): 1290-1297.

Grynberg M, Murphy C, Doré C, Fresneau L, Paillet S, Petrica N, Frédérique M,  Ravonimbola H. A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction  program from a French perspective. J Med Econ. 2018 Nov 21: 1-15.

Scheffer JAB, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? JBRA Assist Reprod. 2018 Sep 1; 22(3): 215-220.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun; 155 Suppl 1: S3-S9.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bull Cancer. 2018 Mar; 105(3): 299-314.

Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H, Najdecki R. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol. Front Endocrinol (Lausanne). 2018 Mar 1; 9: 25.

Grynberg M, Sonigo C, Santulli P. Fertility Preservation in Women. N Engl J Med. 2018 Jan 25; 378(4): 400.

Bénard J, Sermondade N, Grynberg M. Fertility Preservation in Endocrine Disorders during Transition for Girls. Endocr Dev. 2018; 33: 128-148.

Raad J, Sonigo C, Tran C, Sifer C, Durnerin IC, Grynberg M. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor.  Eur J Obstet Gynecol Reprod Biol. 2018 Jan; 220: 140-141.

Sonigo C, Jankowski S, Yoo O, Trassard O, Bousquet N, Grynberg M, Beau I, Binart N. High-throughput ovarian follicle counting by an innovative deep learning approach. Sci Rep. 2018 Sep 10;8(1):13499.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun; 155 Suppl 1: S3-S9.

Grynberg M. The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg. Future Oncol. 2018 Mar; 14(6): 497-498.

Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018 Feb;14(5):483-490.

Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin’s lymphoma when compared with breast cancer candidates for fertility preservation. J Assist Reprod Genet. 2018 Jan;35(1):91-97.

El Hachem H, Sonigo C, Benard J, Presse M, Sifer C, Sermondade N, Grynberg M. Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLoS One. 2018 Dec 6;13(12).

2017

Herbemont C, Sarandi S, Boujenah J, Cedrin-Durnerin I, Sermondade N, Vivot A, Poncelet C, Grynberg M, Sifer C. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? Reprod Biomed Online. 2017 Nov; 35(5): 521-528.

Hugon-Rodin J, Sonigo C, Drummond D, Grynberg M, Rodin T, Plu-Bureau G, Tesniere A. [Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]. Gynecol Obstet Fertil Senol. 2017 May; 45(5): 291-298.

Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, Beau I. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome. BMC Med Genet. 2017 Apr 26; 18(1): 44.

Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH. Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017 Apr-Jun; 11(1): 40-46.

Gronier H, Sonigo C, Bringer S, Cedrin-Durnerin I, Hugues JN, Grynberg M. [Does accumulation of oocytes benefit to women with poor ovarian reserve? No]. Gynecol Obstet Fertil Senol. 2017 Mar; 45(3): 183-184.

Carde PP, Grynberg M, Poirot C, Glimelius B, Mounier N. Reply to C.F. Hess et al. J Clin Oncol. 2017 Jan 20; 35(3): 374.

Sonigo C, Sermondade N, Grynberg M. Letter in reply to « Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations ». Future Oncol. 2017 Mar; 13(7): 591-592.

Le Bras A, Hesters L, Gallot V, Tallet C, Tachdjian G, Frydman N. Shortening gametes co-incubation time improves live birth rate for couples with a history of fragmented embryos. Syst Biol Reprod Med. 2017 Oct; 63(5): 331-337.